Literature DB >> 31806596

Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.

N Dlamini1, M Slim2, F Kirkham3, M Shroff4, P Dirks5, M Moharir2, D MacGregor2, A Robertson2, G deVeber2, W Logan2.   

Abstract

BACKGROUND AND
PURPOSE: Moyamoya is a progressive steno-occlusive arteriopathy. MR imaging assessment of cerebrovascular reactivity can be performed by measuring the blood oxygen level-dependent cerebrovascular reactivity response to vasoactive stimuli. Our objective was to determine whether negative blood oxygen level-dependent cerebrovascular reactivity status is predictive of ischemic events in childhood moyamoya.
MATERIALS AND METHODS: We conducted a retrospective study of a consecutive cohort of children with moyamoya who underwent assessment of blood oxygen level-dependent cerebrovascular reactivity. The charts of patients with written informed consent were reviewed for the occurrence of arterial ischemic stroke, transient ischemic attack, or silent infarcts. We used logistic regression to calculate the OR and 95% CI for ischemic events based on steal status. Hazard ratios for ischemic events based on age at blood oxygen level-dependent cerebrovascular reactivity imaging, sex, and moyamoya etiology were calculated using Cox hazards models.
RESULTS: Thirty-seven children (21 female; median age, 10.7 years; interquartile range, 7.5-14.7 years) were followed for a median of 28.8 months (interquartile range, 13.7-84.1 months). Eleven (30%) had ischemic events, 82% of which were TIA without infarcts. Steal was present in 15 of 16 (93.8%) hemispheres in which ischemic events occurred versus 25 of 58 (43.1%) ischemic-free hemispheres (OR = 19.8; 95% CI, 2.5-160; P = .005). Children with idiopathic moyamoya were at significantly greater risk of ischemic events (hazard ratio, 3.71; 95% CI, 1.1-12.8; P = .037).
CONCLUSIONS: Our study demonstrates that idiopathic moyamoya and the presence of steal are independently associated with ischemic events. The use of blood oxygen level-dependent cerebrovascular reactivity could potentially assist in the selection of patients for revascularization surgery and the direction of therapy in children with moyamoya.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31806596      PMCID: PMC6975325          DOI: 10.3174/ajnr.A6324

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

Review 1.  Moyamoya disease.

Authors:  M Fukui; S Kono; K Sueishi; K Ikezaki
Journal:  Neuropathology       Date:  2000-09       Impact factor: 1.906

2.  Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

Authors:  C Heyn; J Poublanc; A Crawley; D Mandell; J S Han; M Tymianski; K terBrugge; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

3.  Functional MRI statistical software packages: a comparative analysis.

Authors:  S Gold; B Christian; S Arndt; G Zeien; T Cizadlo; D L Johnson; M Flaum; N C Andreasen
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

4.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

5.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

6.  Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures.

Authors:  A M Harper; H I Glass
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-10       Impact factor: 10.154

Review 7.  Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis.

Authors:  Ajay Gupta; J Levi Chazen; Maya Hartman; Diana Delgado; Nikesh Anumula; Huibo Shao; Madhu Mazumdar; Alan Z Segal; Hooman Kamel; Dana Leifer; Pina C Sanelli
Journal:  Stroke       Date:  2012-11       Impact factor: 7.914

Review 8.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

9.  CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: safety, tolerability, and technical feasibility.

Authors:  Vincent R Spano; Daniel M Mandell; Julien Poublanc; Kevin Sam; Anne Battisti-Charbonney; Olivia Pucci; Jay S Han; Adrian P Crawley; Joseph A Fisher; David J Mikulis
Journal:  Radiology       Date:  2012-11-30       Impact factor: 11.105

10.  Prospective targeting and control of end-tidal CO2 and O2 concentrations.

Authors:  Marat Slessarev; Jay Han; Alexandra Mardimae; Eitan Prisman; David Preiss; George Volgyesi; Cliff Ansel; James Duffin; Joseph A Fisher
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

View more
  3 in total

1.  The Significance and Challenge of Quantitative Hemodynamic Study in Moyamoya Disease.

Authors:  J Yu; Q Du; J Chen
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-16       Impact factor: 3.825

2.  Fronto-Parietal and White Matter Haemodynamics Predict Cognitive Outcome in Children with Moyamoya Independent of Stroke.

Authors:  Eun Jung Choi; Robyn Westmacott; Fenella J Kirkham; Amanda Robertson; Prakash Muthusami; Manohar Shroff; Mahendranath Moharir; Tricia Williams; Peter Dirks; Daune MacGregor; Mahmoud Slim; Elizabeth Pulcine; Ishvinder Bhathal; Matsanga Leyila Kaseka; Andrea Kassner; William Logan; Gabrielle deVeber; Nomazulu Dlamini
Journal:  Transl Stroke Res       Date:  2022-03-25       Impact factor: 6.800

3.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.